The impact of patents on plant breeding using biotechnology by Day, Peter R.




Rutgers, The State University of New Jersey
New Brunswick, New Jersey
My first job after graduation was breeding tomato plants for resistance to a 
fungus disease. It was a simple program that involved the introduction of 
dominant genes for resistance, from other cultivars and from wild relatives, 
in a backcrossing program that employed several widely grown cultivars as 
recurrent parents. The first lines from this program appeared to be so promising 
that 1 sent them to some greenhouse tomato growers for small trials. The 
growers agreed that they were resistant to disease but said they were also 
resistant to yield. This taught me the important lesson — that no matter what 
new gene a crop cultivar may contain, unless its genetic background supports 
good agronomic performance it will be of no practical interest to growers and 
farmers. For this reason, a major part of the application of biotechnology to 
plant breeding has been the field trials to prove the agronomic qualities of 
newly engineered forms.
FieldTrial— A GuidetoWhatis  Happening
Goy and Duesing (1995) reported a survey of field trials over the period 1986- 
1993. During this time, they examined records of some 1,025 field trials in 
32 countries. Table 1 (on page 80), adapted from their paper, shows the range 
of characters introduced into the five most widely tested crops. The tobacco 
field trials for the most part reflect its use as an easily transformed crop plant 
model. Although the first field trials were carried out largely by the private 
sector, the first in the UK was a trial of a potato transformant carrying the 
gus marker gene. That trial was carried out in 1986 at the Plant Breeding 
Institute (PBI) in Cambridge. By 1993, the private sector was responsible 
for 71 percent of all trials, although by then a total of 61 public institutions 
and 88 companies had submitted applications or notifications to the various 
regulatory organizations controlling field tests of genetically manipulated 
plants (Goy and Duesing 1995).
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Table  1. Number  of  Field  Trials  and  Traits  Tested
TRAIT Potato Canola Tobacco Corn Tomato
Herbicide resistance 16 (5) 94 (7) 29 (6) 54 (3) 21 (5)
Quality 31 (9) 57 (5) 13 (4) 15 (2) 39 (3)
Virus resistance 60 (12) 2 (2) 24 (7) 10 (4) 20 (9)
Insect resistance 34 (4) 3 (3) 19 (3) 24 (2) 16 (1)
Marker gene 23 (7) 17 (5) 28 (9) 8 (4) 4 (3)
Fungal resistance 9 (7) 5 (4) 9 (4) 2 (1)
Multiple traits 8 (7) 2 (1) 4 (3) 0
Bacterial resistance 9 (3) 1 (1) 0 0
Not specified 3 1 5 5 3
Total 193 181 128 120 105
Data are from 1986 to 1993 Adapted from Goy & Duesing 1995
71 percent of trials are by the private sector
PrivateandPublicPlantBreeding
Throughout the last 50 years some major changes have affected the way 
varieties are released and how breeders are compensated for their work. Plant 
variety rights legislation is now common in many countries and protects the 
originators of new cultivars against theft and illegal sales of seeds and planting 
stocks by unauthorized propagators. In Europe, the introduction of these 
schemes spawned the development of the plant breeding industry by making 
investment in the technology profitable through the return of royalties on seed 
sales. As the private sector grew in strength and capability, there was a steady 
trend away from reliance on public sector plant breeders to produce new 
cultivars of the major agronomic crops. In the UK this culminated in the 
privatization of the Plant Breeding Institute in 1987, leaving only remnants 
of the public sector breeding that had largely supported British agriculture 
over the period from 1910 to the seventies. Although traumatic for those who 
lived through the transition, it re-emphasized the important role of the public 
sector in basic research. However, the demise of the PBI did destroy a unique 
and very successful organization that directly coupled basic and applied science 
for crop plant improvement.
In the U.S. there was a similar, if less dramatic, trend towards a reduced 
reliance on land-grant university and federal breeding programs. Some excep-
tions include crops, such as oats and alfalfa, which the private sector regarded 
as too small, in terms of seed sales, to be profitable. For corn, exclusive 
ownership of the inbred lines needed to make up Fj hybrids provided an 
alternative to plant variety rights.
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Patents
Although plant variety rights provided reasonable protection for conventionally 
bred varieties, the scheme could not protect the hard won fruits of biotech-
nology. The capital and personnel investments in molecular biology were 
considerable. These costs, and the precedents from earlier decisions for 
patenting living organisms, made it clear that utility patents were the answer.
As a result, there has been a tremendous increase in the filing of patents to 
protect discoveries such as cloned genes, methods of effecting transformation, 
and the development of systems for using molecular mapping as an aid to 
selection. At Rutgers, this is reflected in the appointment of additional staff 
to the University Office of Corporate Liaison and Technology Transfer, which 
has six people who assist faculty and graduate students in patent filing. The 
total number of faculty at Rutgers is about 1,100. However, in one U.S. private 
university that evidently has great expectations of continuing to benefit from 
licensing fees and royalty income, the number of staff with this function is now 
approximately one per ten faculty members.
To illustrate my concerns and the practical problems caused by patents, 
let me review a situation that we now face at Rutgers and which 1 am sure 
is paralleled elsewhere. A most successful plant breeding program at Cook 
College is a turfgrass-breeding program led by Reed Funk. This program has 
been responsible for a number of leading varieties that are widely grown in 
North America. In the course of developing a transformation method for one 
of the turf grass species — Agrostis palustris or creeping bentgrass — we made 
use of the bar gene for resistance to the herbicide bialaphos (Hartman et al. 
1994). The bar gene is widely available for research use but two patents cover 
commercial use, as a selective marker in the laboratory, for recovering products 
of transformation, or for field use to confer herbicide resistance. We have also 
worked with several other herbicide resistance genes that have been introduced 
into the same grass species. Following greenhouse and field trials, we had 
expected to begin discussions with the owners or licensees of these patented 
genes to explore how the most promising lines we had selected might find their 
way into the hands of commercial grass breeders. During the course of several 
years of meetings, correspondence and telephone calls, we have encountered 
a number of problems that have made this a far from easy task. Among the 
problems were the following. The patent owners:
1. Have other plans for the use of the gene in more important crops.
2. Fear that herbicide-resistant creeping bentgrass, a species commonly 
used on golf course greens, might escape as a weed and invalidate the 
use of these herbicides on other more important crops.
3. Are concerned that horizontal spread of the genes, by cross-hybridization 
with other native Agrostis spp. that are weeds, could more seriously 
compromise the use of these genes and their relevant herbicides in 
combination.
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4. Some of the owners are concerned about development, and other costs, 
to obtain a registration label authorizing the use of their herbicide on a 
new crop species.
5. In other cases, research agreements prevent us from publicly acknowl-
edging that we have certain genes and are working with them and may 
even prevent publication of our findings.
The first is clearly beyond our control. The second we naively thought would 
be resolved by the lack of any record in the literature that A. palustris is a weed 
species. It has been recorded as a weed in Kentucky bluegrass lawns but the 
absence of any reports that it is not a weed of field crops seems to be of little 
comfort. The third has been in part addressed by hybridization studies carried 
out by breeders to introduce new genetic variation into creeping bentgrass. The 
fourth question is a legitimate concern. Although bentgrass is not part of the 
human food chain, the environmental impact of increased herbicide use on golf 
course greens and eventually on lawns must be considered even though the 
newer herbicides we work with are environmentally benign. They are used at 
low doses, are rapidly biodegraded in the soil, and have very low mammalian 
toxicides.
Even when a public sector unit isolates and clones its own genes, which it 
may well decide to patent, there are still other problems. I am grateful to Ken 
Barton of Agracetus, Inc., for the following example. A new genetically 
engineered cultivar arising from work of this kind has to take account of 
additional patents and protection as follows:
1. The Cohen-Boyer patent for cloning DNA in a plasmid in E.coli, even 
though it only has several years left to run, underpins the technology of 
recombinant DNA.
2. The method of transformation is also subject to patent protection: For 
example, the gene gun is covered by the Sanford & Wolf patent (for 
grasses and ornamentals) whereas the DuPont Co. has patent rights for 
other plant species.
3. The plant material to be transformed may be covered by patents. For 
example an Agracetus patent, that is presently being disputed, gives the 
company rights to all transformed cotton cultivars no matter how they 
are produced. If a named crop cultivar is used, and the new cultivar is 
essentially similar except for the new gene, the owner of the original 
cultivar has rights that must be respected.
4. 1 have already discussed the question of ownership of the gene, or genes, 
that give a genetically engineered cultivar its new features. Nearly all 
single gene traits that have been cloned are protected. However, other 
genes may be required that are owned by other parties. For example, 
markers such as kanamycin resistance, the glucuronidase gene (gus)
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and herbicide resistance may be needed. In order to ensure maximal 
expression at the appropriate stage of plant development, the introduced 
genes must be controlled by elements such as the CaMV 35s promoter, 
an organ or tissue specific promoter, or be used with an expression 
enhancer such as the omega sequence from tobacco mosaic virus (TMV).
Each interested party, or patentee, has to agree to the proposed use of their 
materials under license. Each will expect either an up-front fee, or a share of 
royalty income, which have to be negotiated individually. Small wonder that 
public sector programs with limited resources and experience in negotiating 
licensing fees are finding it increasingly difficult to compete with large 
companies who are patent holders, and thus have bargaining chips to use 
in negotiating deals with each other. In theory, the patent system is supposed 
to make material available for further research by protecting the interests of 
the patent holder. In practice, the patent holder can find many ways to block 
distribution of the patented materials and to limit the uses made of it.
Are patents as useful as publications for evaluating faculty for tenure and 
promotion? Probably not, but they are unlikely to hurt an academic candidate 
and could be regarded as an indicator of his or her awareness of the relevance 
of their work. Patents are, of course, much more important in industry. Judging 
the quality of awarded patents is much more difficult. Patents are examined by 
patent office specialists. They are not peer reviewed, and their treatment is 
entirely different to that given journal articles or grant proposals.
ArePresentIntellectuDO PropertyLawsaBarriertoExchangeandAccess ?
In my view, these laws restrict meaningful access to genetic information. Before 
patent protection is filed for, the investigators are unable to describe their work 
to others for fear of invalidating their patent claims. Even after the patent is 
filed and granted, access to the material can be denied by failure to answer 
requests. Such access as may be granted may not be meaningful since profitable 
use of the materials may be prohibited and, even if allowed, is subject to 
restrictions. The result is that the laws sometimes limit, or even prevent, 
beneficial applications. This is the cost of protecting private sector investment 
in plant improvement. Without it, private plant breeding would not have 
flourished.
What of the trend among universities to patent and protect information 
gained with taxpayer support? Although some have been critical, many believe 
that universities should benefit from the income accruing to such protection. 
They believe that it will reduce the tax burden, enhance facilities for teaching 
and research, reward and encourage faculty inventors, and create wealth and 
jobs for the community. However, these incentives can distract university 
faculty from teaching, research and more traditional forms of service to the
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community. There is the danger that they may become more concerned 
with raising capital, establishing and managing external development or 
manufacturing facilities, and lining their own pockets. Negotiating contracts, 
licenses and royalties has now become so complex that research universities 
must employ specialists in these areas to protect their interests and maximize 
returns. A senior faculty committee at Rutgers recently spent much time in 
revising its scheme for dividing the spoils from royalty income between the 
university central administration and the deans, department chairs and 
researchers themselves.
PresentDayRoleofPubliFSectorBreedingPrograms
Some years ago the late William Brown of Pioneer Hy-Bred International,
Inc., was concerned about the reduction in plant breeding in U.S. land-grant 
colleges. He was worried by the prospect that the private sector would be 
unable to recruit young men and women trained in the technology. During 
several annual seminars organized by Pioneer Hi-Bred in the 1970s that 
brought together public and private scientists, it became clear that training 
in plant breeding would increasingly become the province of private sector 
breeding companies. Their new recruits would have had training over a 
broader range of subjects than before. This would include not only the 
traditional subjects such as genetics, plant physiology, agronomy and 
statistics, but also molecular biology, biotechnology, biochemistry and cell 
biology. Much like engineering trainees, they would learn the idiosyncrasies 
of individual crops, the practice of selection and the management of trials 
in company plots and fields. I believe that this is working well. I am less 
optimistic about the technology transfer of the products of long term basic 
research in plant molecular biology carried on in our universities. The 
separation between basic research and the technologies that need it and 
can make best use of it means that they are uncoupled in our universities.
The problems and pitfalls involved in patenting exacerbate this situation. 
Even producing new breeding lines for release to commercial breeders is 
no longer simple.
I will finish by reviewing my own experience in the UK. In a sense it 
represented for me the culmination of the introduction of Plant Variety 
Rights. I joined the Plant Breeding Institute in Cambridge in 1979. At 
the time its varieties dominated or were prominent on the UK national 
recommended lists for winter wheat, spring barley, potatoes, marrowstem 
kale, and oilseed rape (canola). The National Seed Development Organiza-
tion (a state organization) distributed these, and other products of public 
plant breeding, collected the royalties and passed them on to the Treasury.
By the early 1980s the PBI’s share of these royalties exceeded its annual
84 Genes for the Future: Discovery, Ownership, Access
grant-in-aid from the state. Some of the UK private sector breeders resented 
the success of “Her Majesty’s Plant Breeders” who were supported in part by 
the taxes they paid on their profits. Unlike the system in The Netherlands, 
where state breeders offered the private sector advanced breeding materials 
and were prevented by law from releasing finished varieties, the PBI breeders’ 
best materials went right through to the ultimate test — the farm and the 
marketplace. The competition between state and private breeders, although 
not on an equal footing, was good for the British farmer. For example, there 
had been a steady increase in the proportion of homegrown wheat in bread-
making grists brought about by systematic breeding for breadmaking quality 
coupled with high yield. The end came when the government realized that 
the generation of royalty income was a salable asset and the PBI was priva-
tized in 1987. In my view, the most damaging result was the uncoupling of 
theory (genetics, plant molecular biology and plant pathology) and practice 
that resulted. The dialogue between breeders and others at PBI was at times 
difficult and unrewarding, but in the long run was responsible for the 
achievements made over 75 years.
If we are to benefit from current technologies, that were pipe dreams 15 
years ago, we must facilitate and enhance the coupling between discovery 
and its broad use. Where intellectual property rights and agreements hinder 
this we must strive to find ways to make things work fairly and efficiently.
References
Goy, P.A. and J.H. Duesing. 1995. From pots to plots: genetically modified 
plants on trial. Bio/Technology. 13:454-458 
Hartman, C.L., L. Lee, PR. Day, and N.E. Turner. 1994. Herbicide resistant 
turfgrass (Agrostis palustris Huds.) by biolistic transformation. Bio/ 
Technology. 12: 919-923
Day 85
